Literature DB >> 10735591

Interleukin-1 stimulates human uterine prostaglandin production through induction of cyclooxygenase-2 expression.

P N Rauk1, J P Chiao.   

Abstract

PROBLEM: Uterine infection occurs in as much as 20% of preterm labor and results in increased decidual cytokines. The objective of this study was to examine the effect of interleukin-1 (IL-1) and the cyclooxygenase-2 (COX-2) inhibitor, NS-398, on myometrial prostaglandin (PG) production and COX-2 expression. METHOD OF STUDY: Human uterine myocytes were stimulated with IL-1 (0-50 ng/mL) over 24 hr. PGE2, PGF2alpha, and 6-keto F1alpha were measured by enzyme-linked immunosorbent assay. Both COX-1 and COX-2 proteins and mRNA were measured by western and northern blot, respectively.
RESULTS: IL-1 increased PG production beginning at 6 hr, COX-2 protein increased beginning at 4 hr and continued to increase at 24 hr. COX-2 mRNA increased at 2 hr and peaked at 4 hr. NS-398 blocked PG production but had no effect on COX-2 protein or mRNA.
CONCLUSIONS: IL-1 increases PG production by myometrium by increased COX-2 expression. NS-398 completely blocks IL-1-induced PG production. With intrauterine infection, IL-1 may induce labor through the autocrine production of uterotonic PGs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735591     DOI: 10.1111/j.8755-8920.2000.430304.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  36 in total

Review 1.  Molecular Regulation of Parturition: A Myometrial Perspective.

Authors:  Nora E Renthal; Koriand'r C Williams; Alina P Montalbano; Chien-Cheng Chen; Lu Gao; Carole R Mendelson
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-03       Impact factor: 6.915

2.  A proposed bio-panel to predict risk for spontaneous preterm birth among African American women.

Authors:  Shannon L Gillespie; Lisa M Christian; Jeremy L Neal
Journal:  Med Hypotheses       Date:  2015-07-31       Impact factor: 1.538

Review 3.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

4.  Maternal and fetal intrauterine tissue crosstalk promotes proinflammatory amplification and uterine transition†.

Authors:  Kelycia B Leimert; Angela Messer; Theora Gray; Xin Fang; Sylvain Chemtob; David M Olson
Journal:  Biol Reprod       Date:  2019-03-01       Impact factor: 4.285

5.  Characterization of the myometrial transcriptome and biological pathways of spontaneous human labor at term.

Authors:  Pooja Mittal; Roberto Romero; Adi L Tarca; Juan Gonzalez; Sorin Draghici; Yi Xu; Zhong Dong; Chia-Ling Nhan-Chang; Tinnakorn Chaiworapongsa; Stephen Lye; Juan Pedro Kusanovic; Leonard Lipovich; Shali Mazaki-Tovi; Sonia S Hassan; Sam Mesiano; Chong Jai Kim
Journal:  J Perinat Med       Date:  2010-07-14       Impact factor: 1.901

Review 6.  Gestational tissue inflammatory biomarkers at term labor: A systematic review of literature.

Authors:  Emily E Hadley; Lauren S Richardson; Maria R Torloni; Ramkumar Menon
Journal:  Am J Reprod Immunol       Date:  2017-10-27       Impact factor: 3.886

Review 7.  Cooperative inflammation: The recruitment of inflammatory signaling in marsupial and eutherian pregnancy.

Authors:  Daniel J Stadtmauer; Günter P Wagner
Journal:  J Reprod Immunol       Date:  2019-10-25       Impact factor: 4.054

Review 8.  Fetal-to-maternal signaling in the timing of birth.

Authors:  Carole R Mendelson; Alina P Montalbano; Lu Gao
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-11       Impact factor: 4.292

Review 9.  Minireview: fetal-maternal hormonal signaling in pregnancy and labor.

Authors:  Carole R Mendelson
Journal:  Mol Endocrinol       Date:  2009-03-12

10.  Leukocytes are primed in peripheral blood for activation during term and preterm labour.

Authors:  M Yuan; F Jordan; I B McInnes; M M Harnett; J E Norman
Journal:  Mol Hum Reprod       Date:  2009-07-23       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.